# Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections

> **NCT00934011** · NA · COMPLETED · sponsor: **Federal University of Minas Gerais** · enrollment: 94 (actual)

## Conditions studied

- Severe Sepsis
- Septic Shock

## Interventions

- **OTHER:** C-reactive protein guided antibiotic therapy
- **OTHER:** Procalcitonin guided antibiotic therapy

## Key facts

- **NCT ID:** NCT00934011
- **Lead sponsor:** Federal University of Minas Gerais
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2016-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00934011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00934011, "Use of Inflammatory Biomarkers to Guide Antibiotic Therapy in Patients With Severe Infections". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00934011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*